Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and Immunogenicity of FLUAD in Elderly
NCT01344057Phase 2Completed
- Sponsor
- Novartis
- Start
- May 2011
- Primary completion
- Jun 2011
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of influenza vaccine (surface antigen, inactivated, adjuvanted) in seasonal influenza, sponsored by Novartis. Started May 2011; status: completed.
02
Drugs
influenza vaccine (surface antigen, inactivated, adjuvanted)
03
Conditions
seasonal influenza
Beyond the preview
Go deeper on NCT01344057.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01344057.